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Abstract. Translational Science is receiving increasing attention in order to ac-
celerate the process of developing useful clinical interventions starting with 
basic biological discoveries. The stages in translation are denoted T0, T1, T2, 
T3, T4. The four transitions between stages can pose formidable difficulties and 
are called the four ‘Valleys of Death’. In this paper we suggest that the method-
ologies of Persuasive Technology and Behavior Change Support Systems can 
provide a conceptual and theoretical framework for crossing the valley between 
T2 (Clinical Research) and T3 (Clinical Implementation). We present several 
studies that provide intriguing evidence for this suggestion. 
Keywords: Translational Science, Persuasive Technology, Behavior Change 
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1 Background: Translational Science 
Translational science, also called Translational Medicine, is concerned with the pro-
cess of converting fundamental clinical research findings into clinical practice(s) to 
improve the health of individuals, and ultimately of populations.  In recent years this 
discipline is experiencing a surge in attention. Emphasizing its importance, in 2012 
the US National Institutes of Health created an institute, the National Center for Ad-
vancing Translational Science (NCATS) to support and perform research in Transla-
tional science. A major motivation for this recent interest is the observation that there 
is very often a substantial time lag, accompanied by considerable expense, from basic 
biological discoveries to widespread realization(s) into clinical practice benefiting 
humans and populations. According to some estimates [1] the mean time to imple-
ment a new clinical research finding into practice is 17 to 24 years with correspond-
ingly substantial costs. Thus, there is growing interest in understanding the process of 
translation and decreasing the time lag from basic discovery to useful interventions 
that eventually improve public health.  
The National Center for Advancing Translational Science defines Translation as “the 
process of turning observations in the laboratory, clinic and community into interven-
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tions that improve the health of individuals and the public — from diagnostics and 
therapeutics to medical procedures and behavioral changes”.  NCATS identifies a 
sequence of five stages called the Translational Science Spectrum [2] consisting of 
the following.  Basic Research to reveal “fundamental mechanisms of biology, dis-
ease or behavior”, Pre-Clinical Research that “connects basic science and human 
medicine”, Clinical Research that includes “studies to better understand a disease in 
humans and relate this knowledge to findings in cell or animal models”, Clinical im-
plementation that includes the “adoption of interventions into routine clinical care”. 
This stage also includes “implementation research to evaluate clinical trial results”. 
Finally, in the Public Health stage “researchers study health outcomes at the popula-
tion level”.   
As in any evolving discipline, there is some variation in definitions and terminolo-
gy. The original definitions of translational science included only two stages [3] or 
three stages [1]. In the rest of this paper we will use the terminology in [4] in which 
the above five stages are denoted T0, T1, T2, T3, T4.  
1.1 Translational Valleys of Death 
An interesting viewpoint of Translational Science is presented in [5]. Here, the au-
thors point out that transits from successive stages, i.e. T0 to T1, T1, to T2, T3 to T4 
entail crossing four chasms. These chasms are called “Valleys of Death” because 
transiting them entails very considerable difficulties. For example, in the case of stem 
cell research, crossing from T0 to T1 encountered almost insurmountable political and 
ethical hurdles as well as failures and disappointments in the science and its imple-
mentation [5]. 
In this paper we are concerned with crossing the valley of death between T2 and 
T3, called the T3 valley in [5].  T2 Translational medicine is concerned with “transla-
tion of results from clinical studies into everyday clinical practice and health decision 
making.” [3]. In particular, the goal of research in T2  is to “ improve quality by im-
proving access, reorganizing and coordinating systems of care, helping clinicians and 
patients to change behaviors and make more informed choices, providing reminders 
and point-of-care decision support tools and strengthening the patient-clinician rela-
tionship.”[3]. In [6], the goal of T2 research is defined more precisely as “evidence-
based guidelines and recommendations by professional organizations and independent 
panels”, a description that is echoed in [4]. Regarding T3, in [4] the authors express 
the goal of T3 research to include “concepts and methods to disseminate new clinical 
knowledge for integration into practice, including health services research”. This de-
scription is similar to that in [6] for T3 research. 
1.2 Biomedical Informatics and Translational Science 
The activities listed above as goals of the T2 and T3 stages are topics of great interest 
to biomedical informaticians. An important methodology for helping clinicians and 
patients to change behaviors is to provide informatics tools that support and enable 
them to comply with evidence-based clinical guidelines that promote health, cope 
with chronic disease, or recover from medical conditions such as cancer, or major 
surgery.  For example, currently there is great interest in developing informatics tools 
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that help mitigate and manage chronic and non-communicable diseases such as Type 
II diabetes, hypertension, depression and the like. Healthy persons may need to im-
prove their health and prevent chronic disease such as Type 2 diabetes, and hyperten-
sion, by engaging in health promoting and disease-prevention activities such as exer-
cise, losing excess weight, and proper nutrition. Those who are not ill, but have harm-
ful habits such as alcohol, opioid or tobacco addictions need help to overcome these 
addictions. 
Crossing the valley of death from T2 to T3 can be a daunting task without obvious 
solutions or directions. For example, in [7-9], it is shown that even when equipped 
with paper-based guideline materials the performance of Community Health Workers 
in applying these guidelines in clinical practice can be sub-optimal. In other words, 
the guidelines developed in the T2 stage failed to make a successful transition to T3, 
at least in the implementations investigated in these studies. 
Clearly, the issue is that in order to maximize its impact and enable widespread adop-
tion, T2 research needs to be transitioned into T3 practice in a useful, easy-to-use, 
actionable form, to the intended users that achieves meaningful behavior change. Cur-
rently the translational science literature seems to provide limited guidance for this 
task. However, this issue is receiving increasing attention. For example, in [6] the 
authors identify this activity as an important area of research in its own right, termed 
Implementation Research or Implementation Science. 
 
2 Persuasive Technology 
The Translational Science goal identified in [3], i.e., “helping clinicians and patients 
to change behaviors” corresponds very well with the goal of Persuasive Technology 
(PT) to identify technological attributes that enhance behavior change without coer-
cion [10]. Fogg’s original principles for systems that achieve this goal were as fol-
lows: i) Reduction: The  system should reduce complex tasks/behaviors into simple 
tasks; (ii) Tunneling: The system should lead users through the process or steps need-
ed for the desired behavior change; (iii) Tailoring: The system should frame the tasks 
and task steps in a manner that matches the target user group’s educational, linguistic, 
ethnic/social characteristics; (iv) Personalization: A further refinement of Tailoring to 
match an individual user; (v) Self-monitoring: Enable the user to keep track of their 
performance or progress in meeting the desired behavior change; (vi) Simulation: 
Provide users with the ability to simulate tasks/behaviors; (vii) Rehearsal: The system 
should enable users to walk  through  the desired tasks/behaviors before real-world 
application.  
These principles were extended in [11] to provide a framework, called the Persua-
sive Systems Design (PSD) model to define software requirements to guide develop-
ment of persuasive systems. The PSD model defines three categories, Dialogue Sup-
port, System Credibility Support, and Social Support. Each category includes several 
principles. Details are in [11].  Recently, a cognate area called Behavior Change Sup-
port Systems [12] is also receiving increasing interest. For the sake of brevity we shall 
refer to this spectrum under the collective name Persuasive Technology.  
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2.1 Central Conjecture 
With this background, in this work-in-progress, we suggest that the techniques, prin-
ciples and methodologies of Persuasive Technology can provide a useful conceptual 
and theoretical framework for crossing the T3 valley of death and enhance productiv-
ity in Implementation Research.  
In the remainder of this work-in-progress paper we present some evidence to support 
this conjecture.  
3 Related Work 
3.1 Smartphone implementation of IMCI guidelines  
In 2006 the World Health Organization issued an influential report [13] pointing out 
that the bulk of healthcare providers in developing countries are Community Health 
Workers (CHWs). In many developing countries these CHWs are poorly educated 
and suffer from literacy and educational deficits, in common with the people they 
treat. The WHO further suggested that the care they provide would be improved if 
they practice guideline-based care. An example of such a guideline is the Integrated 
Management of Childhood Illness (IMCI) [14] originally developed by experts at 
WHO and UNICEF as a strategy to promote health and provide preventive and cura-
tive care for children under the age of 5 years. A version specific to newborns under 
the age of one week is IMNCI [15]. These guidelines have been translated into multi-
ple languages including Spanish, where IMCI is known as AIEPI (Atencion Integrada 
a las Enfermedades Prevalentes de Infancia). Clearly, the activity of developing 
IMCI belongs to the T2 stage of translation science. The next step is to translate IMCI 
into clinical practice in developing countries, i.e., to move IMCI into the T3 stage. To 
this end, the WHO publishes textbooks and workbooks for IMCI in both paper and 
the equivalent electronic forms.  Clearly, the effectiveness of IMCI with respect to 
eventual improvement of health outcomes is dependent on the extent to which the 
target audience, i.e., CHWs in developing countries, can understand and apply IMCI.  
However in [15] it is pointed out that practice tools implementing IMNCI the tools 
fall short of meeting needs in many countries. 
In [16, 17] relevant metrics including Procedure compliance, practice errors, and per-
ceived workload of AIEPI for two implementation platforms of IMCI were compared 
in a prospective Randomized Controlled Trial, with 50 CHWs, using a randomized 
cross-over design. The first platform consisted of the AIEPI guidelines on paper. The 
second consisted of Windows Mobile 6.5 smartphones and presented the AIEPI in a 
media-rich step-by-step format that was shown to incorporate major elements of PT, 
Tunneling, Reduction, and Tailoring [18].  
The study [16,17] showed that as compared to paper, the smartphone version of 
IMCI resulted in 35% fewer errors, 30% increase in compliance with AIEPI, greater 
acceptability, usability, intention to use. In addition, perceived workload (cognitive, 
frustration, overall) workload were significantly lower. A study in rural south India, 
with a subset of IMCI in Tamil language, produced similar results [19].  We conjec-
ture that a major proportion of the improved performance of CHWs when using the 
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smartphone tool, as compared to paper-based materials, can be attributed to PT-based 
design of the former. The paper-based guidelines did not, and could not, incorporate 
these principles of PT in a substantial way, and certainly not to the extent that the 
smartphone version of IMCI did. The Smartphone IMCI explicitly supported Reduc-
tion by breaking up the complicated IMCI into small steps to prevent cognitive over-
load. Tunneling was implemented by providing a small number (typically not more 
than two) buttons providing the CHW with a limited number of choices for the next 
step.  Tailoring was supported by providing the information in multiple modalities 
matching the educational attainment of the target CHWs. These included providing 
instructions for a step in audio and/or video enhanced their understanding and ability 
to do clinical tasks such as recognizing signs and symptoms of respiratory distress. 
3.2 Systematic reviews of medication adherence and obesity interventions 
Some more evidence for PT as an effective means for implementing clinical research 
and guidelines is provided in two systematic reviews [20, 21]. In [20], a systematic  
review of  behavioral interventions to enhance compliance with medication guidelines 
by older adults was described. Here, the authors conducted a search in MedLine [22], 
CINAHL[23], and PsycINFO[24] databases for studies in the timeframe 1977 to 2012 
concerning medication adherence among adults aged 60 years and older. The designs 
of these interventions were based upon prior behavioral and clinical research. In other 
words, each study was an attempt to move T2 research into T3 clinical practice. The 
systematic review assessed whether interventions containing principles of PT were 
more effective and which, if any, principles of PT support enhancing medication ad-
herence in this populations. Out of 979 initial results a total of 40 papers met inclu-
sion and exclusion criteria. These studies divided themselves into two self-reported 
categories, 25 successful studies and 15 unsuccessful. For each study, the team exam-
ined the intervention in detail and identified presence or absence of PT and PSD at-
tributes. The successful studies were found to have an average of 3 persuasive attrib-
utes versus 2.25 for the unsuccessful ones. However this difference was not statisti-
cally significant (p = 0.038). The “Tailoring” PT attribute was present significantly 
more often in the successful interventions (p < 0.01). The simulation and reduction PT 
elements were also present more often in the successful interventions but the differ-
ence was not statistically significant. Similar results were found in a systematic re-
view of studies comparing behavioral interventions for obesity control [21].  
Summarizing, these two reviews provide some evidence that PT principles can 
have a beneficial effect on outcomes of interventions in medication adherence and 
obesity control. The interventions belong to the T3 stage of translational science while 
the medical and behavioral theories on which these interventions were based belong 
to the T2 stage. In addition, the intervention design and effectiveness research also are 
of interest in Implementation science. One limitation, that prevented suggestive re-
sults from statistically significant were small sample sizes in the final number of pa-
pers that met inclusion/exclusion criteria.  
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4 Conclusion 
We conjecture that Persuasive Technology, including  Persuasive Systems Design and 
Behavior change Support Systems,  can provide methodologies and techniques for 
translating T2 research into tools that support the practice and implementation of this 
research, i.e., for enabling the translation from T2 to T3 and thereby crossing T3 “val-
ley of death”.  
4.1 Future work and Challenges 
While this paper presents some intriguing evidence, considerable amount of work 
remains to investigate the central conjecture that Persuasive Technology principles 
can provide a theoretical and conceptual framework for T2 to T3 transition in Transla-
tional Science. Large scale systematic reviews comparing interventions, systems, and 
tools, similar to those described above, are needed to establish an evidence base for 
the role of Persuasive Technology in Translational Science. These have to be fol-
lowed by prospective RCTs comparing interventions, systems and tools based on PT 
versus those not using PT principles. An interesting challenge is to develop frame-
works for specific health domains, knowledge and goals (T2 research) and specific 
information and communications technology implementations and target users (T3). 
Such mapping frameworks can potentially be of great service to designers of systems 
and tools, by guiding these designers on the specific features that their tools should 
implement to maximize potential for success.  
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